Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations in sphingolipid metabolism genes are associated with ADHD.
Henriquez-Henriquez M, Acosta MT, Martinez AF, Vélez JI, Lopera F, Pineda D, Palacio JD, Quiroga T, Worgall TS, Deckelbaum RJ, Mastronardi C, Molina BSG; MTA Cooperative Group; Arcos-Burgos M, Muenke M. Henriquez-Henriquez M, et al. Transl Psychiatry. 2020 Jul 13;10(1):231. doi: 10.1038/s41398-020-00881-8. Transl Psychiatry. 2020. PMID: 32661301 Free PMC article.
Trajectories of Growth Associated With Long-Term Stimulant Medication in the Multimodal Treatment Study of Attention-Deficit/Hyperactivity Disorder.
Greenhill LL, Swanson JM, Hechtman L, Waxmonsky J, Arnold LE, Molina BSG, Hinshaw SP, Jensen PS, Abikoff HB, Wigal T, Stehli A, Howard A, Hermanussen M, Hanć T; MTA Cooperative Group. Greenhill LL, et al. Among authors: wigal t. J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):978-989. doi: 10.1016/j.jaac.2019.06.019. Epub 2019 Aug 15. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 31421233 Free PMC article.
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD).
Wigal TL, Newcorn JH, Handal N, Wigal SB, Mulligan I, Schmith V, Konofal E. Wigal TL, et al. CNS Drugs. 2018 Mar;32(3):289-301. doi: 10.1007/s40263-018-0503-y. CNS Drugs. 2018. PMID: 29557078 Free PMC article. Clinical Trial.
The Qualitative Interview Study of Persistent and Nonpersistent Substance Use in the MTA: Sample Characteristics, Frequent Use, and Reasons for Use.
Swanson JM, Wigal T, Jensen PS, Mitchell JT, Weisner TS, Murray D, Arnold LE, Hechtman L, Molina BSG, Owens EB, Hinshaw SP, Belendiuk K, Howard A, Wigal SB, Sorensen P, Stehli A. Swanson JM, et al. Among authors: wigal t. J Atten Disord. 2018 Jul;22(9_suppl):21S-37S. doi: 10.1177/1087054717714058. Epub 2017 Nov 1. J Atten Disord. 2018. PMID: 29090967 Free PMC article.
Lactate Metabolism in Human Lung Tumors.
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, Li H, Huet G, Yuan Q, Wigal T, Butt Y, Ni M, Torrealba J, Oliver D, Lenkinski RE, Malloy CR, Wachsmann JW, Young JD, Kernstine K, DeBerardinis RJ. Faubert B, et al. Among authors: wigal t. Cell. 2017 Oct 5;171(2):358-371.e9. doi: 10.1016/j.cell.2017.09.019. Cell. 2017. PMID: 28985563 Free PMC article.
Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.
Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC; MTA Cooperative Group. Swanson JM, et al. Among authors: wigal t. J Child Psychol Psychiatry. 2017 Jun;58(6):663-678. doi: 10.1111/jcpp.12684. Epub 2017 Mar 10. J Child Psychol Psychiatry. 2017. PMID: 28295312 Free PMC article. Clinical Trial.
117 results